business

Cantor Fitzgerald reiterates Neutral rating on Pfizer stock

Investing.com · Jun 1, 2026, 12:52 PM · Also reported by 4 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance UBS Raises PT On MongoDB (MDB) To $350, Maintains “Neutral” Rating Yahoo Finance KeyBanc Trims PT On Salesforce (CRM) To $290 From $300, Reiterates “Overweight” Rating Yahoo Finance Wall Street Just Cut This Tech Stock's Rating. History Says That's When You Buy. Yahoo Finance Wells Fargo Trims PT On Autodesk (ADSK) to $330 from $350, Reiterates “Overweight” Rating

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Cantor Fitzgerald reiterates Neutral rating on Pfizer stock

Also covered by

More in business